Brand-name drug
Exxua price, strengths & recalls
Brand of gepirone (generic)
Pharmacies pay $1,688.60 for 30 tablets of Exxua 54.5 mg (24 hr) extended-release tablet this week, and from $1,688.60 to $1,842.02 across its 2 priced strengths and forms. Its official label last changed on July 15, 2026.
Brand- Fair cash price
- $1,952.39
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Exxua price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 54.5 mg (24 hr) extended-release tablet Brand | $56.29 | $1,688.60 / 30 tablets |
| Titration pack Brand | $57.56 | $1,842.02 / 32 tablets |
Exxua vs generic gepirone
There is no generic version of Exxua on the market yet. Its last listed patent or exclusivity runs to September 2, 2030 - generics often follow, though court cases and settlements can move the date either way.
GenericGepirone pricesSupply status: shortages & recalls
What people paid for Exxua
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use EXXUA ™ safely and effectively. See full prescribing information for EXXUA. EXXUA( gepirone) extended-release tablets for oral use Initial U.S. Approval: 2023
BOXED WARNING
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors
[see
Warnings and Precautions
(5.1)]
. EXXUA is not approved for use in pediatric patients
[see
Use in Specific Populations (8.4)]
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
See full prescribing information for complete boxed warning.
Increased risk of suicidal thinking and behavior in pediatric and young adult patients taking antidepressants. Closely monitor for worsening and emergence of suicidal thoughts and behaviors (
5.1). EXXUA is not approved for use in pediatric patients (
8.4).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021164 · Fabre Kramer
- First approved
- September 22, 2023 (3 years ago)
- Latest approved change
- June 7, 2025
- Approved label
- PDF, Jun 10, 2025
- Generic makers
- None on the market
- Last patent listed
- September 2, 2030
- Exclusivity ends
- September 22, 2028
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Exxua questions
How much does exxua cost without insurance?
Pharmacies pay about $1,688.60 for 30 tablets of exxua 54.5 mg (24 hr) extended-release tablet ($56.29 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,952.39. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Exxua?
Yes: gepirone. Compare gepirone prices.
Is exxua in shortage?
No shortage is reported for exxua right now. We check the national shortage list every day.
Has exxua been recalled?
No recalls are on record for exxua.
When did the exxua label last change?
The official label was last updated on July 15, 2026 (version 3). See what changed.
Talk about exxua
No comments yet. Questions, tips, what worked for you - start the conversation.